Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) rose 1.3% during trading on Monday . The company traded as high as $1.07 and last traded at $0.78. 3,314 shares were traded during mid-day trading, an increase of 47% from the average daily volume of 2,257 shares. The stock had previously closed at $0.77.
Nutriband Trading Up 1.3%
The firm’s fifty day moving average price is $1.17 and its two-hundred day moving average price is $1.35.
Hedge Funds Weigh In On Nutriband
A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP purchased a new position in Nutriband Inc. (NASDAQ:NTRBW – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises 0.1% of Empery Asset Management LP’s holdings, making the stock its 20th largest position.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Read More
- Five stocks we like better than Nutriband
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
